The BSAVA Guide to the Use of Veterinary Medicines has been developed to help veterinary professionals navigate the regulations, changes and issues that face the profession when it comes to the use of veterinary medicines.
Edited by David Harris and Pam Mosedale, there are three new sections which cover:
The BSAVA also highlights that the law in the UK relating to the use of veterinary medicines will be updated when the VMD completes its review.
In addition changes to the RCVS Code of Conduct concerning under care are due to come into force in September.
This, the Association says, will lead to significant changes in medicines use, as well as legal and ethical dilemmas.
As a result, the new guide includes a section at the beginning of the Guide that will be updated as required and the editors encourage all veterinary professionals to stay up to date with the progress of these reviews.
The new BSAVA Guide to the Use of Veterinary medicines is freely available to all via the BSAVA Library.
Zoetis, formerly Pfizer Animal Health has launched Ovatec Plus, which it claims will make equine faecal collection and in-practice worm count testing quicker and easier.
Ovatec Plus is designed to facilitate the in-house detection of worm burdens by enabling the coproscopic examination of parasite eggs, larvae and cysts. Zoetis says the built-in sample collection scoop allows for hands-off, quick, clean sample collection and controlled sample size, while the built-in cap, which can be written on for easy identification, snaps shut to seals the contents safely for contamination-free transport.
The system is based on zinc sulphate flotation technology, with a flotation time of ten minutes to provide rapid analysis. The Ova-Spin feature will break up difficult samples. The positive-locking filter chamber prevents any spill of test samples and reduces operator exposure to potential hazards. The overflow reservoir prevents overfills leaking onto the lab bench.
Zoetis says the high sensitivity and excellent specificity of Ovatec Plus enable informed treatment decisions to be made. A study has shown that samples proving negative with Ovatec Plus provide 95% certainty that the sample is <150epg and 100% certainty that the sample is <250epg, which means treatment may not be necessary1. Samples that prove positive, with one or more eggs seen, can be verified using a quantitative technique if needed, alternatively treatment may be indicated.
Ben Lacey, equine business unit manager at Zoetis, said: "Ovatec Plus is an excellent addition to our equine worm control portfolio. It's ideal for use in many test situations, giving a quick, easy and convenient solution."
To find out more, speak to your Zoetis Account Manager, call 0845 300 8034 or email CustomerSupportUK@zoetis.com.
Reference
The two best research projects were selected on the awards day with Sara Hillyer from the University of Bristol School of Veterinary Sciences winning the £1,000 top prize for her project on vascular endothelial glycocalyx shedding in clinical disease in cats and dogs.
Nicola Mawson from the Royal (Dick) School of Veterinary Studies won the £500 runner-up prize for her project on feline tooth resorptive lesions.
The other four successful candidates were Emily Clark from the University of Nottingham School of Veterinary Medicine & Science, Luca Fortuna from the Royal Veterinary College London, Jessica Lam from the Royal (Dick) School of Veterinary Studies, and Xaquin Castro Dopico from the Royal (Dick) School of Veterinary Studies. Each were awarded £1000 towards their research.
Michelle Townley, Veterinary Advisor and Bursary Co-ordinator at MSD Animal Health said: "We were delighted that we had so many applications this year and again the standard of research and presentation was extremely high. The winning students presented on a very wide range of research areas and selecting just two winners proved extremely hard. It is very encouraging to see such enthusiasm for research in the vets of the future."
Applicants were judged on the quality and clarity of their research project, and their ability to clearly communicate their conclusions.
Applications for the MSD Animal Health Veterinary Student Research Bursary 2018 will be opened early next year. For further information, visit: www.msd-animal-health.co.uk/company-overview/student-research-bursary.aspx
For the research1, 190 faecal samples were collected from dogs in 140 households (114 samples from raw fed dogs and 76 from non-raw fed dogs).
Salmonella species was detected in 4% of the samples (all raw fed) and antimicrobial-resistant E. coli was detected in 40% of all dogs, but in 62% of raw fed dogs.
The authors say that statistical analysis confirmed that this represented a significantly higher prevalence of AMR E. coli, including multidrug resistance and third generation cephalosporin resistance, and Salmonella species in dogs fed raw compared to non-raw meat diets.
The authors concluded that strategies should be implemented to increase the awareness of the risks of feeding raw meat diets to dogs, to reduce any potential risk to owners, their families, and their pets.
Nicola Di Girolamo, Editor of JSAP says: “In this study, an association between raw meat diets in dogs and faecal carriage of potentially dangerous enteric bacteria has been observed.
"Readers should keep in mind that cross-sectional studies such as this one lay the basis for additional research more suited to prove causality.”
Ceva Animal Health has announced that Vetergesic (buprenorphine), its long-lasting analgesic, is now back in stock and on special offer with the rest of the company's analgesic product range.
The company says it has appointed a new, dedicated Vetergesic manufacturing site and increased stock-holding facilities in order to guarantee a continuous long-term supply of the product, which is available in a 10ml vial for use in dogs, cats and horses and a 1ml single dose preparation for cats and dogs.
At the same time, Ceva has launched a spring offer on its entire analgesic product range, which runs till the end of April. For every two packs of Vetergesic, Carprodyl F or Dolagis purchased, veterinary practices will receive one pack free and for every four packs of Meloxidyl purchased, practices will receive one pack free. In addition, practices will be able to take advantage of ongoing rebates through the new CevaSave Rebate Programme.
For further information, contact your local Ceva territory manager, email analgesics-group@ceva.com or call 01494 781510.
Elanco Companion Animal Health has launched a competition to encourage veterinary professionals to showcase the company's new range of practice support materials for the company's parasiticides, Comfortis and Trifexin.
To enter the competition, you'll first need to order the support materials, which include: waiting room posters, client leaflets and a waiting room leaflet dispenser, modular window hangers, social media artwork and display kits which consist of 19 die-cut colour pieces for waiting room displays. Entry / order forms are available here.
Then create your display and email a digital photograph of it to Elanco before the 29th August 2014.
Matthew Rowe, Senior Brand Manager at Elanco said: "We're asking veterinary practices to use their creativity and imagination when putting up their parasite control displays. Last year's winner, the Animal Health Centre in Torquay, even composed their own song, so the more creative the better!"
The overall winner will win a team celebration worth £1000, and there are £250 Amazon vouchers for 11 regional winners.
For further information contact your local Elanco Companion Animal Health key account manager or email elancocahuk@elanco.com
Alstoe is launching Vetergesic Multidose, a 10ml version of the opiate injection, in a new multi-use vial.
Alstoe Technical Director, Dr Ian Ryder said: "In addition to the new vial size the inclusion of a preservative enables Vetergesic Multidose to be used for up to 28 days following its initial use. Also the product is now licensed for intravenous administration."
Vetergesic Multidose should drastically reduce the amount of product wasted by practices using the old, smaller single-use vial.
Alstoe says that supplying Vetergesic in a multi-use vial was one of the first things discussed with the drug originators, Reckitt Benckiser, when it took over the marketing of the product. However, for a large scale medical pharmaceutical manufacturer to consider producing a veterinary product in a different pack and in much smaller production runs than their medical operating scales, the answer is normally no. But in this case, Reckitts gave the project its full support, so in addition to reduced wastage, the inconvenience of snapping glass necks will become a thing of the past.
Please contact Alstoe Ltd for further information at info@alstoe.co.uk or telephone 01347 878606.
Vetsonic UK has announced the addition to its range of Vetericyn Super 7+, a brand new umbilical cord dry-out solution for use in calves, lambs, piglets, foals, kids and puppies which is designed as an alternative to iodine.
Vetsonic says that because Super 7+ contains no iodine, it won't encourage licking by iodine-deficient mothers, which can cause serious damage to the navel. It is also an ideal alternative for handlers who are prone to iodine allergies.
The company points to a US study conducted by Auburn University in which Super 7 + demonstrated more than double the desiccation efficacy in the first 24 hours when compared to 7% tincture of iodine.
Super 7+ contains a dye for easy identification of treated animals and the company says it is environmental friendly, safe, non-flammable and non-corrosive with no toxic fumes.
Super 7 + is now available through veterinary wholesalers and direct from Vetsonic (UK) Ltd, either in a 500 ml spray bottle (box of 6) or a 3.78 litre bottle for dipping.
For more information, visit www.vetsonic.com
The case was brought by the College after a member of the public raised a 'concern' relating to Mrs Mullen's practice in December 2015. The concern was not pursued by the College.
However, during its initial investigation, the RCVS case manager ascertained that contrary to the requirements of the Code of Professional Conduct, Mrs Mullen did not have PII.
In January 2016 Mrs Mullen was advised by the College that, in order to comply with the Code, she needed to ensure her professional activities were covered by PII or equivalent arrangements.
The matter was considered by the Preliminary Investigation Committee which asked, in October 2016, that Mrs Mullen produce evidence that she was now compliant with the requirement to have PII or equivalent. Mrs Mullen responded in November 2016 confirming that she had not put in place such arrangements.
The case was then referred to the Disciplinary Committee in January 2017.
During the hearing it was determined that, during the relevant time period (from November 2015 to November 2016) Mrs Mullen was practising but did not have professional indemnity insurance in place and therefore was in breach of the Code.
Mrs Mullen, who represented herself, told the Committee that she admitted that she did not have PII. She explained that she was 'ethically and morally opposed to it' as she felt that it did not give fair compensation to claimants and did not know it was a requirement of the Code of Professional Conduct until she was informed by the College in January 2016.
When giving oral evidence as to equivalent arrangements she disclosed that she kept significant funds in a bank account; these were not however specifically earmarked for use in the event of any possible claims, and were also required to pay practice expenses.
In light of evidence produced by the College and her own admissions, the charges against Mrs Mullen were found proved and she was found guilty of disgraceful conduct in a professional respect.
In coming to this decision Chitra Karve, chairing the Committee and speaking on its behalf, said: "The respondent failed to have PII in place for a period of about 12 months as specified in the charges. Moreover, she failed to remedy the situation when advised in January 2016 by the College that she was in breach of the Code and the supporting guidance. This remains a continuous course of conduct, which has still not been remedied. The respondent has chosen not to read the Code, or the supporting guidance, until very recently, in relation to her obligation to have PII or equivalent arrangements in place, and she failed to heed the advice of the College that she must rectify the position."
In considering the sanction the Committee took into account mitigating and aggravating factors. Aggravating factors included the fact that the misconduct was sustained over a significant period of time and that limited insight was shown by Mrs Mullen. While she did begin to display limited insight into the significance of her misconduct, the Committee said that this insight was "hampered by her ambivalence towards the College and the systems that regulate the veterinary profession."
In mitigation the Committee took into account Mrs Mullen’s long and unblemished career and the fact she was a sole practitioner who reported challenging personal circumstances and provided a unique service to a niche group of clients.
However, Chitra Karve said: "The Committee is unable to overlook the Respondent’s lack of commitment to obtaining PII or equivalent arrangements, even after being advised by the College that this was essential. The Committee is aware that a suspension could adversely affect her practice and her clients that she uniquely serves. However the Committee thinks it is necessary to send a clear message to the respondent and the public, that failure to obtain PII or equivalent arrangements is wholly unacceptable."
She added: "Accordingly, the Committee directs the Registrar to suspend the respondent’s registration for a period of two months. The Committee considers that this period of suspension will give the respondent an opportunity to rectify her breaches of the Code in relation to PII… and to reflect upon her attitude towards the College and the appropriate regulation of the veterinary profession."
The company says the initiative, which is targeted at veterinary professionals and farmers, will be supported by an extensive social media, advertising and PR campaign.
The social media campaign will take the form of social media content, newsletter articles and images for veterinary practices to use on their social media channels and will include information on the cost of dairy cow lameness and tips to manage lameness.
Rose Jackson BVSc DBR CertVBM MRCVS is the farm clinical director at Scarsdale Vets which has already trialled the new materials. She said: “The ‘Wave Goodbye to Pain’ social media content has ensured that we are able to post eye-catching and thought-provoking content to continue to engage with our clients and raise awareness of the ‘triple works’ approach to lameness in cows, which includes using a NSAID such as Ketofen, alongside a trim and block for a more complete recovery from lameness than trimming alone.”
The ‘Wave Goodbye to Pain’ campaign was launched following a study by Nottingham University which revealed that NSAIDs have a synergistic effect when given alongside effective hoof trimming and blocking to treat lameness1.
The study looked at claw horn disease of the hind foot and found that trimming alone resulted in a 69% rate of return to mobility without lameness in 35 days. Adding a block into an effective trimming protocol raised the success rate to 72%; trimming and administering a NSAID raised it to 76%. Interestingly, using all three techniques together - trimming, applying a block and administering an NSAID - resulted in 85% of cases being successfully resolved (Mobility score or 0 or 1).
Gemma Robinson BVM BVS MRCVS, ruminant veterinary adviser at Ceva Animal Health, said: “The study highlights that effective and prompt pain relief with NSAIDs can quickly help restore animals back to full productivity. Attitudes on the use of pain relief have changed significantly over the last 10 years and dairy farmers can have a positive influence by ensuring they recognise the value of NSAIDs and prioritise their use on-farm. It is important that vets discuss NSAIDs with their clients, both to manage illness and for routine procedures, and our ‘Wave Goodbye to Pain’ campaign will help encourage farmers to think about their current pain management plan, take action and seek help from their vet.
“Some concerns have been raised that the issues associated with antimicrobial resistance and antibiotic administration are causing farmers to avoid the use of all injectable treatments. We need to be clear that NSAIDs are anti-inflammatories, not antibiotics, and it is important they are used for pain management, fever and the clinical signs associated with many common conditions. With zero milk-withhold NSAIDs available - there really is no reason to hesitate when it comes to administering pain relief in otherwise healthy cattle.”
For more information on the ‘Wave Goodbye to Pain’ campaign visit the website designed for farmers (www.wavegoodbyetopain.co.uk), contact your local Ceva territory manager or call 01494 781510.
To request a copy of the ‘Wave Goodbye to Pain’ social media pack (including pre-developed posts and images which you can send out to your own clients), speak to your Ceva territory manager or email: cevauk@ceva.com with your name, practice name and address details.
References
Zoetis has announced the launch of Zulvac SBV, a new Schmallenberg vaccine licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.
Zulvac SBV is licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.
Duration of immunity is six months in cattle and seven in sheep. At the recommended vaccination timing, this covers the window of susceptibility during pregnancy; in sheep from day 28 to 56, and days 70 to 150 in cattle. Animals infected during these periods are at risk of malformed offspring and subsequent stillbirth.
The company says vaccination combined with insecticidal measures to control the midge vector remains the most effective way of protecting the population1 and ensuring a more unified level of immunity.
Zoetis vet Carolyn Hogan said: "Although SBV is now considered to be an enzootic pathogen in England and Wales, there is plenty of evidence that seroprevalence at farm level – particularly on sheep farms - varies. As immunity wanes, the proportion of herds and flocks naïve to SBV and at risk via introduction of naïve replacements increases. So the risk of reinfection in assumed enzootic areas is potentially underestimated2.
"Culicoides midges, the SBV vector, are widespread in Europe and move easily between farms and regions, allowing rapid spread of infection."
Carolyn says that whilst there have been no confirmed diagnoses of congenital abnormalities in calves or lambs from APHA in 2014 or 2015, unconfirmed anecdotal cases have been reported.
"We do not know whether our ruminant population is immune or susceptible and neither do we know if another SBV challenge will appear. Vaccination remains the most effective way of ensuring valuable livestock are protected."
Supplies are available immediately.
Alstoe Animal Health has announced that Vetergesic (buprenorphine), the UK's most commonly used injectable opiate for small animal use, is now registered for use in horses.
Developed and manufactured in the UK, Alstoe took over marketing Vetergesic 11 years ago. Two years ago the company introduced the Multi-Dose Pack, which it says allows veterinary surgeons to manage the larger liquid volumes required in horses more easily.
Alstoe says Vetergesic potentiates sedative drugs for standing sedation or routine premedication and provides profound centrally acting analgesic effects for up to nine hours. In routine procedures, this allows good recoveries and a rapid return to normal behaviour patterns.
Alstoe also says that in a thermal anti-nociceptive study carried out at Bristol University, Vetergesic showed significantly better analgesic effects than butorphanol. Field studies carried out in the UK also confirmed that when combined with a sedative, Vetergesic can provide up to 60 minutes of operating time, with smooth and quick recoveries.
John Nellis of Alstoe said: "We have invested heavily in this product and are confident that the rewards enjoyed by small animal vets will also be appreciated by their equine colleagues. We call Vetergesic 'the thoroughbred of pain management'."
Vetergesic Multidose is available for dogs, cats and horses in a 10 ml vial.
Alstoe offers an hour long explanatory seminar, which can be delivered directly to practice members. An 8 page brochure and 'pocket-sized' dose chart are also available. Further details from Alstoe on: 01347 878606 or email: info@alstoe.co.uk .
In addition, less than half of those surveyed knew the correct temperature for vaccine storage, showing there is a lack of knowledge surrounding standard procedures.
Paul Williams, MSD Animal Health UK technical manager for ruminants said: "Failing to maintain the correct fridge storage temperature compromises vaccine effectiveness and consequently animal health.
"In a significant number of farm fridges monitored, the temperature was elevated to 80C for long periods of time, with the maximum fridge temperature recorded being 240C.
"In the worst cases, over 60% of fridges had been at 0 0C or below 0 0C long enough for vital contents to freeze. When the temperature is too high, vaccines become ineffective. If frozen, the vaccine is destroyed.
"This research shows we have work to do in educating customers about how to store vaccines and I encourage all farmers to check their farm fridge temperatures.
"To promote better practice, we’ve launched an awareness campaign called Fridge Check to educate farmers on the importance of storing vaccines correctly.
"The campaign is being promoted by Disease? Not On My Farm!, an initiative helping farmers take a more proactive approach to preventing disease on farm."
To find out more, visit the Disease? Not On My Farm! Facebook and Twitter pages or follow the hashtag #FridgeCheck for more information about how to store vaccines correctly.
There is a need to raise farmers’ awareness of correct vaccine storage temperatures. Williams P. (MSD Animal Health), Paixao G. (University of Bristol).
Eravac is an injectable emulsion ready for administration without the need for reconstitution beforehand. Containing 10 vials with individual doses, the new presentation is is indicated for the immunisation of pet rabbits from 30 days of age.
For more information, visit: https://www.hipra.com/portal/en/hipra/animalhealth/products/detail/eravac-pets
In an internal study, Royal Canin found that Pill Assist Cat achieved over 91% pill acceptance.
Pill Assist Cat is enriched with vitamins and prebiotics to support a cat’s recovery, and each treat contains only three calories.
Elisabete Capitao, Royal Canin Veterinary Marketing Manager said: "We know that getting cats to take pills can be quite a challenge even for the most experienced pet owners! A quarter of owners leave the veterinary clinic with oral medication for their cat, but 40% find giving pills to their cat complicated. Pill Assist Cat makes giving cats medication easy and takes the stress out of pill time."
Royal Canin says Pill Assist Cat is suitable for most types of medication, from worming tablets to medication for an illness.
The webinar will cover the entire disease process of MMVD in dogs from pathology to current treatment approaches and future advancements in therapy, and will include the following presentations:
https://us06web.zoom.us/webinar/register/WN_QyfUofLgRG-YsaXQbkT7Tw#/registration
Stefano qualified in Parma, Italy and has a Master’s in Clinical Oncology. He has worked in a number of referral practices, managing and treating small animal oncological cases. He also has an interesting history of working with animals across the globe: he has a Master’s in Tropical Veterinary Medicine and worked with the United Nations in Somalia, Malaysia and Guyana in wildlife management.
Founder, CEO and Clinical Director of The Ralph, Shailen Jasani said: "We had always planned to include an oncology service here at The Ralph though not quite this soon after opening. However, over the last eight months, this has been one area of veterinary medicine where we have not been able to serve our patients, their carers or our referral community. This did not sit well with us. Serendipity being what it is, our path crossed with Stefano's and we were able to extend our services."
For more information, visit www.theralph.vet
Norbrook Laboratories has launched Noroseal, a new teat sealant containing a unique anti-infective ingredient.
The company says that Noroseal, a 2.6g intramammary suspension, is the only teat sealant in the market-place in Europe to contain a PVP-Iodine excipient.
Dr Barry McInerney MVB, MRCVS, PhD, Norbrook GB Veterinary Advisor said: "Noroseal, with its unique formulation, offers vets a proven barrier against intramammary infections during the dry period.
"New bacterial infections occur most often during the first three weeks of drying off because the cow's natural keratin plug is not completely formed. Indeed, approximately 50% of teat canals are still open for up to seven days after drying off. Noroseal Teat Sealant will mimic the cow's keratin teat barrier offering immediate protection against infection. Additionally, the anti-infective ingredient, PVP-Iodine, complements the effectiveness of the teat-sealant components in the teat canal barrier."
Norbrook says that the estimated annual cost of mastitis to the UK dairy industry is in excess of £168M with a single case of clinical mastitis costing farmers approximately £178.00 per cow.
Dr McInerney added: "Clinical mastitis is a costly business but one that can be avoided if timely action is taken. There are various treatments available for dealing with mastitis but studies have shown that the risk of clinical mastitis may be reduced by up to 50% by using a combination of teat sealant and dry cow intramammary therapy. Noroseal is therefore an ideal combination with Norbrook's dry cow therapies such as Noroclox DC, Bovaclox DC Xtra and Bovaclox DC."
Noroseal is available in packs of 24 or buckets of 120 units. A range of promotional material is also available to veterinary practices via the Norbrook Sales Team.
The referral centre has invested in a new heart and lung machine, and an oxygen cage, and is expected to take its first patients in the autumn.
The service will be established and led by head of cardiac surgery Poppy Bristow (pictured right) and head of cardiology Anne Kurosawa, who have already performed this kind of surgery on more than 100 dogs to date.
DWR is also setting up its own blood transfusion service to collect blood from staff and clients’ pets to support the service.
The blood collected will also be used to support the practice’s emergency and critical care service and its planned dialysis programme.
Poppy said: “There are hardly any other centres in the world offering this type of surgery, especially with this level of expertise that comes from the collective team we have gathered at DWR.
“Mitral valve disease is the most common heart condition in dogs and sadly, many dogs die every year as there are very few options for treatment. To be able to offer surgery to more dogs and their owners is really exciting.
“DWR is the perfect environment for this pioneering programme, due to the state-of-the-art equipment and depth of expertise on hand to support this life-saving initiative.”
Rob Foale, clinical director at Dick White Referrals, added: “It’s a hugely significant step for us to be launching this service, drawing on Poppy’s expertise in this field.
“We’re also starting our own blood transfusion service to complement the launch, as the pandemic has led to a huge drop in pet blood donations.
“Any excess blood we collect will be donated to the national Pet Blood Bank charity, which supplies blood to veterinary practices across the UK and does a fantastic job.”
For more information, visit www.dickwhitereferrals.com.
Virbac has launched Deltanil, a deltamethrin-based pour-on solution indicated in dairy and beef cattle for use against flies and lice with a zero milk withdrawal period. It is also effective in sheep against ticks, lice, keds and blowfly strike and against lice and ticks in lambs.
Deltanil is presented for use with the company's Farmpack and Flexibag dispensing system, which was awarded the 2014 PharmaPack Award for Innovative Packaging. Virbac says the system offers farmers a convenient approach to treatment, combining easy application with freedom of movement and the flexibility of a long stability period once the product is opened.
The Farmpack backpack holds a 2.5 litre Flexibag of Deltanil solution, sufficient for the treatment of 250 cattle.
The Flexibag is a flexible, multi-layered, multi-component bag designed to protect and preserve medication, giving Deltanil a two year proven stability period after opening. Unopened, Deltanil has a three year shelf life.
Virbac Product Manager for Large Animals Brigitte Goasduf MRCVS said: "External parasites are a year-round threat to dairy and beef herds and can have a significant economic impact on yields. With the launch of Deltanil, we are offering a new approach to product application, one which is ideally suited to the practical conditions on farm and which addresses the challenges often faced in using pour ons.
"We believe that Deltanil, with its zero milk withdrawal period for dairy cattle and sheep and innovative Farmpack and Flexibag dispensing system, sets a new standard for products of this type.
"Deltanil is based on deltamethrin, a tried and trusted parasiticide. It offers a convenient approach to administration with a 10ml dosage per cow, irrespective of weight, and is presented in two sizes - the 2.5 litre Flexibag and a 1litre dispensing bottle. The 1litre bottle offers a year's stability once opened. The dosage per sheep is 5ml, irrespective of weight, with a 2.5ml dosage for lambs."
The awards, comprising academic book vouchers, were presented at the University’s RCVS ceremony after graduation earlier this month.
Jamie Rahman BVSc won the award for the most engaged veterinary student on EMS placement. Feedback about his placement included: 'Exceptional attitude'. 'Contributed actively to good clinical discussion'. 'Intelligent and engaging’. 'Shows true dedication to learning as much as he can whilst in practice, trying to spend as much time with the different specialists as possible'.
Meanwhile, Cheviot Vets in Alnwick won the students' award for outstanding clinical EMS placement 2019. Comments received from students included: ‘I would not be nearly as prepared and ready for practice without the support and training of the team at Cheviot Vets.’ ‘They invested an incredible amount of time into helping me develop my husbandry knowledge and skills.’ ‘Really supportive manner and encouraged me to develop my skills.’
Sarah Heming, Director of Public Affairs and Customer Relations at Zoetis said: "Zoetis has a high focus on supporting the professional advancement of the veterinary profession. We are proud sponsors of the EMS Recognition Awards for Bristol University alongside other initiatives such as the Young Vet of the Year Awards in partnership with the British Veterinary Association.
"The initial stages of a veterinary career are pivotal so helping winning individuals to invest in academic or professional resources to support their continued development in practice can be very beneficial. We would also like to formally thank the winning practices for their invaluable commitment and support."
The RCVS is inviting responses from veterinary surgeons, veterinary nurses and animal owners to a call for evidence on the provision of 24-hour emergency veterinary care, in order to understand how best to meet the expectations of all those involved.
In an open letter to the profession and the public published on the RCVS website, the Chairman of the RCVS Standards Committee, Clare Tapsfield-Wright, said:
"Over the past two years, lay people working with the RCVS have raised questions about the veterinary profession's ability to provide 24/7 to the extent required by the RCVS Code of Professional Conduct, and said there is a disconnect between the public's expectations and the profession's capacity to meet those expectations."
Clare also refers to an RCVS Disciplinary Committee Inquiry in June 2013, which raised a number of issues on home visits by veterinary surgeons, including: speed of response; travelling time and distance; daytime versus out-of-hours obligations; individual versus corporate responsibility; and, staffing levels and contingency plans.
The letter is accompanied by a range of background information, including the reports of Lay Observers to the RCVS Preliminary Investigation Committee; Working Party reports from the College's 2009 consultation on 24-hour emergency cover; and, further details about the June 2013 DC Inquiry.
The College says additional feedback will be sought through next year's RCVS Survey of the Professions, and via focus group research for animal owners. Once all responses have been collated, a number of individuals and organisations will be invited to a Standards Committee meeting to present and discuss their views.
Responses in writing are invited by 5pm on Monday, 17 February 2014, and should be emailed to 24-7@rcvs.org.uk or posted to the Professional Conduct Department, Royal College of Veterinary Surgeons, Belgravia House, 62-64 Horseferry Road, London SW1P 2AF.
Ms Buttler was charged with having been under the influence of alcohol whilst at work on two separate occasions. On both occasions, she was working as a locum veterinary nurse.
The first occasion was between 25th and 28th April 2016 in Frome, and the second from 3rd July to 4th July 2016 in Salisbury.
It was also alleged that a prior conviction of drunk driving on 19th November 2013 rendered her unfit to practise as a veterinary nurse.
The Committee decided to hear the case in Ms Buttler’s absence as it was satisfied that she had properly been served with the notice of hearing and because she had stated that she was aware of the proceedings but did not wish to engage with the process. The Committee also noted that she had not requested any adjournment.
The Committee heard from five witnesses for the first charge, including three veterinary nurses and one veterinary surgeon. They gave testimony that they had had cause to suspect that Ms Buttler was under the influence of alcohol whilst at work due to her demeanour, and recalled Ms Buttler repeatedly retreating upstairs to her accommodation during the working day. Further, an open wine bottle was found in Ms Buttler’s accommodation and was observed to have been drunk during the course of her shift. The Committee found the first charge proved.
The Committee heard from four witnesses in respect of the second charge. Two of the witnesses stated that they smelt alcohol on Ms Buttler’s breath while she was on duty, with one of them stating that Ms Buttler had slurred speech and a flushed face at the end of a fourteen-hour shift. The other two witnesses also presented evidence to support the assertion that Ms Buttler was under the influence of alcohol whilst at work, while the Committee found that Ms Buttler lacked credibility because she had denied having any alcohol on the premises when originally confronted, but later admitted in an email to the College that she had had an open bottle of wine in her bag. The Committee found the second charge proved.
The Committee then considered the third charge, namely the conviction in 2013. The Committee considered the certificate of conviction obtained from the North East Devon Magistrates Court and was satisfied that Ms Buttler had been convicted of driving with excess alcohol as set out within charge 3.
When considering whether these all amounted to a finding of disgraceful conduct in a professional respect, the Committee was concerned about Ms Buttler showing no insight into her drinking, and the repeated nature of the offences. The Committee also considered that being under the influence of alcohol when working as a veterinary nurse was conduct which fell far short of the standards to be expected of members of the veterinary nursing profession.
It therefore concluded that Ms Buttler was guilty of disgraceful conduct in respect of charges 1 and 2.
The Committee then considered whether Ms Buttler’s conviction (charge 3) rendered her unfit to practise as a veterinary nurse. The Committee concluded that Ms Buttler had not acknowledged the seriousness of her actions in 2013, or learnt any lessons from it. Accordingly, it felt that she continued to pose a risk to animals and the public in the future. The Committee also felt that the conviction undermined the reputation of the veterinary nursing profession because the offence inevitably involved a risk of injury to herself and other road users.
Having found Ms Buttler guilty of misconduct, the Committee went on to consider sanction.
The Committee took into account aggravating factors, including that there was a risk of injury to an animal, the fact that the first two charges involved an element of premeditation, the fact that Ms Buttler was under the influence on more than one shift in each practice, that there is no evidence of insight from Ms Buttler and there is a future risk to animals if she continued to practice unrestricted.
They also considered mitigating factors, including the fact that this is the first disciplinary hearing she has faced, that she did not cause any harm to any animal and that she did not gain financially from her conduct.
In reaching its decision Jane Downes, chairing the Committee and speaking on its behalf, said: "The Committee noted that Ms Buttler said she had worked for twenty years without any problem and that she was previously of good character. However because there was no evidence that Ms Buttler would not repeat the conduct with regards to working whilst under the influence of alcohol she could continue to pose a risk to animals or the public in the future. The Committee therefore was bound to consider her removal from the register.
"Although it noted from the brief email correspondence Ms Buttler had sent to the College that she said she did not intend to practice in the future, the Committee decided that until she had shown insight into her behaviour in 2016, she remained a risk to animals. It therefore decided that the proportionate action was to instruct the Registrar to remove her name from the register of veterinary nurses forthwith."
If Ms Buttler chose to re-engage with the College, she could apply for restoration to the register after ten months.
According to the company, coprophagia affects 23% of dogs, with 16% being repeat offenders.
Copro-nil is a powder which, when added to food, makes the resultant faeces unpalatable. This, says the company, breaks the coprophagia habit and gives the owner an opportunity to implement training to eradicate the behaviour long-term.
Copro-nil has been relaunched in smaller 100g pots with a new look designed to make the product more appealing.
The product comes with advice about behavioural training methods to help owners understand how they can break the coprophagia habit in the long term.
Will Peel, product manager at TVM UK said: "The new format and packaging have been designed to help deal with this very unpleasant problem which many owners believe is a behaviour that dogs will grow out of.
"The new format is intended to demonstrate that Copro-nil, combined with effective behavioural training, can help resolve the problem effectively.’
Copro-nil also provides a comprehensive B vitamin source as deficiencies in B vitamins may contribute to coprophagia.
Downloadable advice sheets for veterinary staff to share help and advice with clients are available from www.tvm-uk.com/coprophagia.
For the study, 2,834 seizure incident cases were identified from a population of 455,553 dogs attending VetCompass participating practices in 2013.
The study found that that approximately 1 in 160 dogs under first opinion veterinary care are affected by seizures every year.
Many of those dogs will have underlying epilepsy, defined as dogs with two or more unprovoked seizures at least 24 hours apart. Seizures can be secondary to idiopathic epilepsy, structural epilepsy or epilepsy of unknown cause.
Until now, however, there has been little information on the classifications of seizures, diagnostic approaches, or clinical management of dogs with seizures in the veterinary first opinion population.
The main findings from the research were:
Dr Dan O’Neill, Senior Lecturer in Companion Animals Epidemiology at the RVC, and author of the paper, said: "Watching your dog undergo a seizure can be an incredibly scary moment for any dog owner. It is really important that dogs that seizure are rapidly diagnosed to decide whether they need no further treatment beyond careful monitoring or alternatively require a clinical work-up to define the cause of the seizures.
"There are now some excellent treatments for many seizure-related diseases. This study helps up to understand the current state of play for seizure management in dogs and identifies opportunities for improved care of these affected dogs."
The full paper is freely available from Journal of Veterinary Internal Medicine and can be accessed here: https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.15911